Xatral XL (Alfuzosin) is a medication classified as an alpha-1 blocker used in the management of benign prostatic hyperplasia (BPH). It works by selectively blocking alpha-1 adrenergic receptors in the prostate, bladder base, and urethra, leading to relaxation of smooth muscles. This relaxation improves urinary flow and reduces BPH symptoms. Clinical studies have shown that Xatral XL can effectively relieve symptoms such as urinary frequency, urgency, weak stream, and nocturia associated with BPH. It is important to follow the prescribed dosage and consult a healthcare provider for proper management.